Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma (2015)
Fonte: The New England Journal of Medicine. Unidade: FM
Assuntos: LINFOMA (DIAGNÓSTICO;TRATAMENTO), FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, MORTALIDADE, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBAK, Tadeusz et al. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. The New England Journal of Medicine, v. 372, n. 8, p. 944-953, 2015Tradução . . Disponível em: http://www.nejm.org/doi/full/10.1056/NEJMoa1412096. Acesso em: 09 set. 2024.APA
Robak, T., Huang, H., Jun, J., Zhu, J., Liu, T., Samoilova, O., et al. (2015). Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. The New England Journal of Medicine, 372( 8), 944-953. doi:10.1056/NEJMoa1412096NLM
Robak T, Huang H, Jun J, Zhu J, Liu T, Samoilova O, Pylpenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma [Internet]. The New England Journal of Medicine. 2015 ; 372( 8): 944-953.[citado 2024 set. 09 ] Available from: http://www.nejm.org/doi/full/10.1056/NEJMoa1412096Vancouver
Robak T, Huang H, Jun J, Zhu J, Liu T, Samoilova O, Pylpenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma [Internet]. The New England Journal of Medicine. 2015 ; 372( 8): 944-953.[citado 2024 set. 09 ] Available from: http://www.nejm.org/doi/full/10.1056/NEJMoa1412096
